Chemoinformaics analysis of S-allyl mercaptocysteine
| Molecular Weight | 193.293 | nRot | 6 |
| Heavy Atom Molecular Weight | 182.205 | nRig | 2 |
| Exact Molecular Weight | 193.023 | nRing | 0 |
| Solubility: LogS | -1.658 | nHRing | 0 |
| Solubility: LogP | -0.315 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 25.8587 |
| nHD | 3 | BPOL | 17.3933 |
| QED | 0.332 |
| Synth | 3.954 |
| Natural Product Likeliness | 0.207 |
| NR-PPAR-gamma | 0.756 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.014 |
| CACO-2 | -5.831 |
| MDCK | 0.00000428 |
| BBB | 0.12 |
| PPB | 0.586148 |
| VDSS | 0.324 |
| FU | 0.370147 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.11 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.774 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.318 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.034 |
| CL | 5.556 |
| T12 | 0.899 |
| hERG | 0.004 |
| Ames | 0.005 |
| ROA | 0.046 |
| SkinSen | 0.608 |
| Carcinogencity | 0.178 |
| EI | 0.929 |
| Respiratory | 0.518 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.929473 |